Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
BJOG : an International Journal of Obstetrics and Gynaecology|July 9, 2020
Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling studyEel Jansen, S K Naber, C A Aitken, et al.
British Journal of Cancer|January 1, 1997
Non-progression of cervical intraepithelial neoplasia estimated from population-screening dataA B Bos, M van Ballegooijen, G J van Oortmarssen, et al.
International Journal of Cancer|March 15, 1990
Cervical-cancer screening: attendance and cost-effectivenessM A Koopmanschap, G J van Oortmarssen, H M van Agt, et al.
Social Science & Medicine (1982)|January 1, 1990
Economic aspects of cervical cancer screeningM A Koopmanschap, K T Lubbe, G J van Oortmarssen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 10, 2012
Having a Pap smear, quality of life before and after cervical screening: a questionnaire studyI J Korfage, M van Ballegooijen, B Wauben, et al.
British Journal of Cancer|June 1, 1992
Preventive Pap-smears: balancing costs, risks and benefitsM van Ballegooijen, J D Habbema, G J van Oortmarssen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Diagnostic and treatment procedures induced by cervical cancer screeningM van Ballegooijen, M A Koopmanschap, G J van Oortmarssen, et al.
British Journal of Cancer|November 13, 2003
Extended duration of the detectable stage by adding HPV test in cervical cancer screeningM E van den Akker-van Marie, M van Ballegooijen, L Rozendaal, et al.
British Journal of Cancer|January 1, 1997
Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectivenessM van Ballegooijen, M E van den Akker-van Marle, P G Warmerdam, et al.
Pageof 6